⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9694838 | 1.00 | — | — | |
| SCHEMBL2675782 | 1.00 | — | — | |
| SCHEMBL679489 | 1.00 | — | — | |
| SCHEMBL7804 | 1.00 | — | — | |
| SCHEMBL8015149 | 1.00 | — | — | |
| SCHEMBL1890701 | 1.00 | — | — | |
| SCHEMBL8661925 | 1.00 | — | — | |
| SCHEMBL21774 | 1.00 | — | — | |
| SCHEMBL8420181 | 1.00 | — | — | |
| SCHEMBL11234658 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109924-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS | VIFOR (INTERNATIONAL) LTD. (CH) | 2024-04-04 | — | — | US | claimed |
| WO-2024023360-A1 | IP5 SUBSTITUTED COMPOUNDS | SANIFIT THERAPEUTICS, S.A. (ES) | 2024-02-01 | — | — | WO | claimed |
| EP-4284809-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2023-12-06 | — | — | EP | claimed |
| CN-116745304-A | IP4-4,6 substituted derivative compounds | 萨尼菲特治疗有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-20230029252-A1 | FUCOSYLATED CHONDROITIN SULFATE OLIGOSACCHARIDE, PREPARATION METHOD THEREFOR, COMPOSITION THEREOF AND USE THEREOF | Yantai Dongcheng Biochemicals Co., Ltd (CN) | 2023-01-26 | — | — | US | claimed |
| EP-3819302-A1 | FUCOSYLATED CHONDROITIN SULFATE OLIGOSACCHARIDE, PREPARATION METHOD THEREFOR, COMPOSITION THEREOF AND USE THEREOF | Yantai Dongcheng Biochemicals Co., Ltd (CN) | 2021-05-12 | — | — | EP | claimed |
| US-RE46955-E1 | Sulfated oligosaccharide derivatives | PROGEN PG500 SERIES PTY LTD (AU) | 2018-07-17 | — | — | US | claimed |
| EP-2205616-B1 | NOVEL SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN PHARMACEUTICALS LTD (AU) | 2016-04-27 | — | — | EP | claimed |
| US-20150065440-A1 | SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN PG500 SERIES PTY LTD (AU) | 2015-03-05 | — | — | US | claimed |
| US-8828952-B2 | Sulfated oligosaccharide derivatives | PROGEN PHARMACEUTICALS LIMITED (AU) | 2014-09-09 | — | — | US | claimed |
| US-20020160981-A1 | Compositions containing an association of aspirin and an anti-Xz oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin | SANOFI-SYNTHELABO (FR) | 2002-10-31 | — | — | US | claimed |
| US-6391339-B1 | ADMINISTERING PENTASACCHARIDE ANTICOAGULANT | AKZO NOBEL N.V. (NL) | 2002-05-21 | — | — | US | claimed |
| US-20020040012-A1 | Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits | SANOFI-SYNTHELABO (FR) | 2002-04-04 | — | — | US | claimed |
| EP-0984785-A1 | USE OF OLIGOSACCHARIDE FOR PREVENTING BLOOD CLOTTING IN EXTRACORPOREAL BLOOD CIRCUITS | Akzo Nobel N.V. (NL) | 2000-03-15 | — | — | EP | claimed |
| WO-1998053829-A1 | USE OF OLIGOSACCHARIDE FOR PREVENTING BLOOD CLOTTING IN EXTRACORPOREAL BLOOD CIRCUITS | AKZO NOBEL N.V. (NL) | 1998-12-03 | — | — | WO | claimed |
| EP-0663391-B1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | HOFFMANN LA ROCHE (CH) | 1997-04-09 | — | — | EP | claimed |
| US-4402944-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1983-09-06 | — | — | US | claimed |
| US-4342753-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1982-08-03 | — | — | US | claimed |
| EP-0008154-A1 | Ureylene phenylene anionic naphthalene-sulfonic acids, their use as complement system inhibitors in a body fluid and process for their preparation | AMERICAN CYANAMID COMPANY (US) | 1980-02-20 | — | — | EP | claimed |
| US-4185032-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1980-01-22 | — | — | US | claimed |